Diclofenac sodium suppository in the treatment of primary nocturnal enuresis

descriptionPublicationkeyboard_double_arrow_right Article 01 Mar 1992 English Publisher:Springer Science and Business Media LLCJournal:International Urology and Nephrology, volume 24, pages 113-117 (issn: 0301-1623, eissn: 1573-2584,

Copyright policy )

Authors: A, Metin; N, Aykol;

doi: 10.1007/bf02549637

pmid: 1624253

Diclofenac sodium suppository in the treatment of primary nocturnal enuresis

- Summary
- Subjects
- Metrics

Abstract

The prostaglandin synthesis inhibitor diclofenac sodium was given as suppository in the treatment of primary nocturnal enuresis in 24 patients. The statistically significant difference in response to diclofenac sodium and to placebo leads us to use diclofenac sodium in primary nocturnal enuresis.

Keywords

Male, Placebos, Diclofenac, Suppositories, Humans, Female, Enuresis, Child

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	8
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average